- P-ISSN 1010-0695
- E-ISSN 2288-3339
- 권한신청
- P-ISSN1010-0695
- E-ISSN2288-3339
논문 상세
Home > 논문 상세
Beakdugu-tang, Traditional Korean Digestant Medicine, Inhibits Hepatic Steatosis in Insulin Resistance Cell Model with HepG2 and THP-1
대한한의학회지 / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2017, v.38 no.2, pp.53-60
https://doi.org/10.13048/jkm.17017
(동국대학교 한의과대학 진단학)
(동국대학교)
(동국대학교 한의과대학 진단학)
(동국대학교)
(동국대학교)
(동국대학교)
(동국대학교)
(동국대학교 한의과대학 진단학)
(동국대학교)
(동국대학교)
(동국대학교)
김혁,
임동우,
박성윤,
박선동,
박원환,
&
김재은.
(2017). . 대한한의학회지, 38(2), 53-60, https://doi.org/10.13048/jkm.17017
- 다운로드 수
- 조회수
Abstract
Objectives: Beakdugu-tang (BDGT) consists of three medicinal herbs, and this prescription has long been used in treatment of various digestant problem in Korea. In this study, we designed to clarify mechanisms by which Korean traditional digestive medicine, BDGT, may exert anti-hepatic steatosis effects via improved insulin resistance cell model in human hepatocellular carcinoma (HepG2) and monocyte (THP-1). Materials and methods: The preparation of BDGT and constituents were extracted with 70% ethanol. HepG2 and THP-1 were treated with different concentrations of BDGT and constituents in the presence and absence of stimulants such as free fatty acids (FFAs) and oxidized low-density lipoprotein (ox-LDL), respectively. Results: The BDGT and its constituents inhibited the FFAs-stimulated lipid accumulation in HepG2 cells. Ethanol extracts of Amomum cardamomum (ACE) improved the ox-LDL induced insulin resistance in THP-1 cells. Also, treatment of monocytic cells with ACE increased anti-hepatic steatosis related gene levels including ABCA, ABCG and SR-B1. Conclusion: The results suggest that the ethanol extract of BDGT and its constituents potently inhibit the FFAs- and ox-LDL induced liver steatosis via improved insulin resistance.
- keywords
- Beakdugu-tang, hepatic steatosis, insulin resistance, digestant medicine
참고문헌
1
1. Richard J, Lingvay I. Hepatic steatosis and type 2diabetes: current and future treatment considerations. Expert Rev Cardiovasc Ther. 2011;9(3):321-8.
2
2. Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?. World J Gastroenterol. 2014;20(27):9072-89.
3
3. Lee DH, Han JM, Yang WM. The effects of Atractylodes japonica Koidz. on type 2 diabetic rats. J Korean Med. 2015;35(1):75-85.
4
4. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Prattey RE, et al. Hypoadiponectinemia in obesity and type 2diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930-5.
5
5. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA. 2011;108(39):16381-5.
6
6. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49(12):2063-9.
7
7. Mitchell PL, Nachbar R, Lachance D, St-Pierre P, Trottier J, Barbier O, et al. Treatment with a novel agent combining docosahexaenoate and metformin increase protectin DX and IL-6production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice. Diabetes Obes Metab. 2017;19(3):313-9.
8
8. Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol. 1998;138(3):269-74.
9
9. Kwon OJ, Lee SW, Paik SH, Han SR, Ahn YM, Ahn SY, et al. The effects of Platycodi radix on obese type 2 diabetes mouse model induced by high fat, high carbohydrate diet. J Korean Med. 2013;34(1):1-14.
10
10. Lim DW, Bose S, Wang JH, Choi HS, Kim YM, Chin YW, et al. Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways. Sci Rep. 2017;30(7):45425.
11
11. Lim DW, Kim H, Park JY, Kim JE, Moon JY, Park SD, et al. Amomum cardamomum L. ethyl acetate fraction protects against carbon tetrachloride -induced liver injury via an antioxidant mechanism in rats. BMC Complement Altern Med. 2016;16:155.
12
12. Kobayashi Y, Hara N, Sugimoto R, Mifuji -Moroka R, Tanaka H, Eguchi A, et al. The associations between circulating bile acids and the muscle volume in patients with non-alcoholic fatty liver disease (NAFLD). Intern Med. 2017;56(7):755-62.
13
13. Lee KP, Kim JE, Kim H, Chang HR, Lee DW, Park WH. Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells. BMC Complement Altern Med. 2016;16:306.
14
14. Um ES, Kim YC. Effect of samhwangsasim-tang and daehwanghwangryunsasim-tang on palmitate -induced lipogenesis in HepG2 cells. J Korean Med. 2016;37(1):62-76.
15
15. Heo J. Translated Dongeuibogam. 1st ed. Seoul:Bubinmunwha. 1999.
16
16. Ulla A, Alam MA, Sikder B, Sumi FA, Rahman MM, Habib ZF, et al. Supplementation of Syzygium cumini seed powder prevented obesity, glucose intolerance, hyperlipidemia and oxidative stress in high carbohydrate high fat diet induced obese rats. BMC Complement Altern Med. 2017;17:289
17
17. Huang Q, Wang T, Yang L, Wang HY. Gisenosied Rb2 alleviates hepatic lipid accumulation by resorting autophagy via induction of Sirt1 and activation of AMPK. Int J Mol Sci. 2017;19(18):E1063.
18
18. Zhang M, Liu C, Hu MY, Zhang J, Xu P, Li F, et al. High-fat diet enhanced retinal dehydrogenase activity, but suppressed retinol dehydrogenase activity in liver of rats. J Pharmacol Sci. 2015;127(4):430-438.
19
19. Gotoh K, Masaki T, Chiba S, Ando H, Fujiwara K, Shimasaki T, et al. Effects of hydrophilic statins on renal tubular lipid accumulation in diet-induced obese mice. Obes Res Clin Pract. 2013;7(5):e342-352.
20
20. Bonora E, Targher G. Increase risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9(7):372-381.
21
21. Masarone M, Rosato V, Aglitti A, Bucci T, Caruso R, Salvatore T, et al. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PLOS One. 2017;12(6):e0178473.
22
22. Bastard JP, Maachi M, Lagath C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12.
- 다운로드 수
- 조회수
- 0KCI 피인용수
- 0WOS 피인용수
권호 내 다른 논문
- Beneficial Effects of Natural Environment Therapy for Atopic Dermatitis
- Inhibition of mTOR signaling pathway by aqueous extract of Siberian ginseng
- Sub-acute toxicity and effect of Hwangryunhaedok-tang on human drug-metabolizing enzymes
- Effect of acupuncture on memory function in old rats
- Effect of Skin Lipid Barrier Formation on Hataedock Treatment with Douchi
- Beakdugu-tang, Traditional Korean Digestant Medicine, Inhibits Hepatic Steatosis in Insulin Resistance Cell Model with HepG2 and THP-1
- Effect of Gamiondam-tang (GMODT), a Polyherbal Formula on the Pharmacokinetics Profiles of Tamoxifen in Male SD Rats
- Case Report for a Refractory Levator Ani Syndrome Treated with Traditional Korean Medication
- Improvement of Pneumonia in a Patient with Non-Small Cell Lung Cancer Treated with Herbal Medicine after Cessation of Antibiotics – a Case Report
- more
추천 논문
학술지 홈페이지 이용 환경은 크롬 브라우저 사용을 권장합니다.